Hamet P., Tremblay :
Novel Genetic Approaches to the Resolution
of Complex Diseases
Fulltext
|
651 |
Widimský J.:
Treatment in the Primary Prevention of Stroke - Still Not Fully Used Option
Fulltext
|
657 |
Jindřichova Š., 1 Vlček P., Bendlová B.:
Genetic Causes ofthe Thyroid Carcinomas
|
664 |
Kovárník T., Aschermann M.:
Regression of Atherosclerotic Plaques during Treatment with Statins
|
669 |
'Šedová L., Šeda O.:
Nutrition Genomics
|
676 |
Charvát J., 'Vychodil P., 'Kieslichová E., Smrčková I., Hložánek I.:
Thromboelastography in Liver Transplantation, a Comparison with
Conventional Laboratory Tests
|
679 |
Xeníček M., '• 'Muchová L., l' 'Vítek L.:
Nuclear Factor kappa B in the Treatment of Inflammatory and Tumor Diseases
|
680 |
Obořilová A., Mayer J, Kořístek Z., Hofmanová Ž., Vášova I., Navrátil M., 'Vinklárková J., 'Muzikářova M., Klabusay M., 2Matuška M:
Evaluation ofthe Clinical Effectivity and Toxicity ofthe FDN Regimen (Fludarabin, Mitoxantron, Dexamethason) in Patients with FoUicular Lymphoma
|
685 |
Malíř F., 'Ostrý V., 2Černá M., 3Kačerovský J., Roubal, T., 'Škarková, J., 3Brndiar M., 4Fixa P.:
Monitoring The Important Mycotoxin Biomarkers (ochratoxin A, aflatoxin Mj) in the Czech Population
|
691 |
Špička I., Klener P.:
Proteasome inhibitors - New Option in the Treatment of Tumor Diseases
|
701 |
Čermáková Z. , 'Stach J., Ryšková O.:
A Severe Čase with Respiratory Insufficiency
|
705 |
Kočárek E., Novotná D., Maříková T., 'Černáková I., 2Lošan F. 'Balíček P., 4Baxová A., Havlovicová M., Goetz P.:
Čase Reports ofPatients with a Marker Chromosome
|
708 |
Coleman T.* Překlad: Králíková E., Himmerová V.:
ABC of Smoking Cessation. Use ofSimple Advice and Behavioural Support
|
713 |
